These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29785160)

  • 1. Observational study of the bisphosphonate-related osteonecrosis of jaws.
    Lungu AE; Lazar MA; Tonea A; Rotaru H; Roman RC; Badea ME
    Clujul Med; 2018; 91(2):209-215. PubMed ID: 29785160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I; Magopoulos C; Karakasis D
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA; Schubert MM; Peterson DE; Seneda LM
    Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw.
    Khan AA; Sándor GK; Dore E; Morrison AD; Alsahli M; Amin F; Peters E; Hanley DA; Chaudry SR; Dempster DW; Glorieux FH; Neville AJ; Talwar RM; Clokie CM; Al Mardini M; Paul T; Khosla S; Josse RG; Sutherland S; Lam DK; Carmichael RP; Blanas N; Kendler D; Petak S; St-Marie LG; Brown J; Evans AW; Rios L; Compston JE;
    J Rheumatol; 2008 Jul; 35(7):1391-7. PubMed ID: 18528958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes.
    Lerman MA; Xie W; Treister NS; Richardson PG; Weller EA; Woo SB
    Oral Oncol; 2013 Sep; 49(9):977-983. PubMed ID: 23830962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw.
    Cicciù M; Herford AS; Juodžbalys G; Stoffella E
    J Craniofac Surg; 2012 May; 23(3):784-8. PubMed ID: 22565901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteonecrosis of the jaws by long term therapy with bisphosphonates].
    Piesold JU; Al-Nawas B; Grötz KA
    Mund Kiefer Gesichtschir; 2006 Sep; 10(5):287-300. PubMed ID: 16960697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT; Amenedo C; Freeman K; Kraut RA
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder.
    Dannemann C; Grätz KW; Riener MO; Zwahlen RA
    Bone; 2007 Apr; 40(4):828-34. PubMed ID: 17236837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.
    Lehrer S; Montazem A; Ramanathan L; Pessin-Minsley M; Pfail J; Stock RG; Kogan R
    J Oral Maxillofac Surg; 2009 Jan; 67(1):159-61. PubMed ID: 19070762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of bone regeneration of a necrotic mandible with pathologic fracture in an elderly hemodialysis patient with medication-related osteonecrosis of the jaw: a case report and review of the literature.
    Yoshizawa K; Moroi A; Iguchi R; Takayama A; Goto J; Takayama Y; Ueki K
    J Med Case Rep; 2021 Dec; 15(1):608. PubMed ID: 34937568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw With Plasma Rich in Growth Factors After Dental Implant Surgery: A Case Report.
    Gil IG; Ponte BM; Mateo ST; García JJ
    J Oral Implantol; 2019 Aug; 45(4):289-296. PubMed ID: 31207196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the jaws in patients treated with bisphosphonates.
    Ata-Ali F; Ata-Ali J; Flichy-Fernández AJ; Bagan JV
    J Clin Exp Dent; 2012 Feb; 4(1):e60-5. PubMed ID: 24558527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
    Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
    Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.